340B Drug Pricing Program Public Comments

RE: 340B Rebate Model Pilot [HHS Docket No. HRSA–2025–14619] (September 8, 2025)

RE: CMS Proposed Exclusion of 340B Drug Units from Medicare Inflation Rebate Calculations (September 5, 2025)

RE: Written testimony to the Office of Management & Budget in support of the manufacturer drug rebate model for the 340B Drug Pricing Program (June 25, 2025)

RE: Testimony in opposition to Connecticut House Bill No. 6870 (“AN ACT CONCERNING PATIENTS’ PRESCRIPTION DRUG COSTS”) (March 10, 2025)

RE: Testimony in opposition to Connecticut Senate Bill No. 8 (“AN ACT CONCERNING DRUG AFFORDABILITY”) (March 18, 2024)

RE: U.S. Senate Bipartisan 340B Working Group Request for Information – 340B Drug Pricing Program (July 24, 2023)

RE: Louisiana House Bill 548 - 340B Drug Pricing Program (June 7, 2023)

RE: HIV Community Concerns Over S.4395 (August 15, 2022)